GTx
12:39 :
GTX rallies 12% on FDA update -
BOSTON (MarketWatch) -- Shares of GTx Inc. shot up 12% to $3.48 Tuesday on news that the U.S. Food and Drug Administration is allowing the company to proceed with a Phase II clinical trial for its drug Capesaris in the treatment of prostate ...
12:15 :
GTX soars 35% on analyst upgrade reports -
BOSTON (MarketWatch) -- Shares of
GTX Inc. soared 35% to $5.33 on Monday on reports that analysts at
Citigroup had raised their price target on the biotech stock to $19 a share.Market Pulse Stories are Rapid-fire, short news ...
11:27 :
GTX gains on analyst rating -
BOSTON (MarketWatch) --
GTX Inc. shares gained 8% to stand at $4.64 in midday trading Wednesday. On Monday, analysts at Wedbush Securities initiated coverage of the stock with an outperform rating and price target of $13.Market Pulse Stories ...
actualidad GTx -